WS23.3 ICM is sensitive to detect potentiation of CFTR-mediated Cl− secretion in patients with cystic fibrosis and the G551D mutation treated with ivacaftor

✍ Scribed by Graeber, S.Y.; Hug, M.J.; Sommerburg, O.; Mainz, J.G.; Heinzmann, A.; Tümmler, B.; Mall, M.A.

• Book ID: 124113991
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 61 KB
• Volume: 13
• Category: Article
• ISSN: 1569-1993
• DOI: 10.1016/S1569-1993(14)60134-X